nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

01.11.2009 | Original Paper

Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction

verfasst von: Shambhunath Choudhary, Hwa-Chain Robert Wang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Reveal mechanisms for the novel proapoptotic ability of oncogenic H-Ras to increase cell susceptibility to a histone deacetylase inhibitor (HDACI) FR901228 for inducing caspase activation and selective apoptosis.

Methods

Human urinary bladder cancer J82 and oncogenic H-Ras-expressing J82 cells were used to reveal differential induction of intracellular reactive oxygen species (ROS), caspase activation, and apoptosis by HDACI FR901228. ROS levels and caspase-8, -9, and -3/7 activities were measured by flow cytometry and luminescence assays, respectively. Specific inhibitors were used to suppress caspases and ROS. Western blot analysis determined modulators of caspase pathways.

Results

ROS, caspase activity, and cell death was differentially increased by FR901228 in oncogenic H-Ras-expressing J82 versus parental cells. Blocking ROS resulted in reduced FR901228-induced cell death and caspase activation. Suppression of caspase-8 resulted in reduced FR901228-activated caspase-9 and -3/7. Suppression of caspase-9 resulted in reduced FR901228-activated caspase-3/7. Although FR901228 induced an ROS-dependent increase of FasL, FasL failed to induce caspase activation and cell death.

Conclusion

Increased ROS played an important role in the activation of the extrinsic and intrinsic caspase pathways to cooperatively induce executioner caspase-3/7 through a novel FasL-independent pathway in FR901228-induced selective apoptosis of oncogenic H-Ras-expressing J82 versus parental cells.

Adachi M, Zhang Y, Zhao X, Minami T, Kawamura R, Hinoda Y, Imai K (2004) Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells. Clin Cancer Res 10:3853–3862. doi:10.1158/1078-0432.CCR-03-0806 PubMedCrossRef

Adjei AA (2001) Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 93:1062–1074. doi:10.1093/jnci/93.14.1062 PubMedCrossRef

Alexandre J, Batteux F, Nicco C, Chéreau C, Laurent A, Guillevin L, Weill B, Goldwasser F (2006) Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119:41–48. doi:10.1002/ijc.21685 PubMedCrossRef

Alexandrova AY, Kopnin PB, Vasiliev JM, Kopnin BP (2006) ROS up-regulation mediates Ras-induced changes of cell morphology and motility. Exp Cell Res 312:2066–2073. doi:10.1016/j.yexcr.2006.03.004 PubMedCrossRef

Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, Lucas DM, Reed JC, Grever MR, Byrd JC (2003) Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 102:652–658. doi:10.1182/blood-2002-12-3794 PubMedCrossRef

Barrientos A, Moraes CT (1999) Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem 274:16188–16197. doi:10.1074/jbc.274.23.16188 PubMedCrossRef

Benard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, Rossignol R (2007) Mitochondrial bioenergetics and structural network organization. J Cell Sci 120:838–848. doi:10.1242/jcs.03381 PubMedCrossRef

Boatright KM, Salvesen GS (2006) Mechanisms of caspase activation. Curr Opin Cell Biol 15:725–731. doi:10.1016/j.ceb.2003.10.009 CrossRef

Bolden JE, Peart MJ, Johnstone RW (2006) Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5:769–783. doi:10.1038/nrd2133 PubMedCrossRef

Buyru N, Tigli H, Ozcan F, Dalay N (2003) Ras oncogene mutations in urine sediments of patients with bladder cancer. J Biochem Mol Biol 36:399–402PubMed

Cheng YT, Li YL, Wu JD, Long SB, Tzai TS, Tzeng CC, Lai MD (1995) Overexpression of MDM-2 mRNA and mutation of the p53tumor suppressor gene in bladder carcinoma cell lines. Mol Carcinog 13:173–181. doi:10.1002/mc.2940130307 PubMedCrossRef

Cho HJ, Jeong HG, Lee JS, Woo ER, Hyun JW, Chung MH, You HJ (2002) Oncogenic H-Ras enhances DNA repair through the Ras/phosphatidylinositol 3-kinase/Rac1 pathway in NIH3T3 cells. Evidence for association with reactive oxygen species. J Biol Chem 277:19358–19366. doi:10.1074/jbc.M200933200 PubMedCrossRef

Choudhary S, Wang HCR (2007a) Proapoptotic ability of oncogenic H-Ras to facilitate apoptosis induced by histone deacetylase inhibitors in human cancer cells. Mol Cancer Ther 6:1099–1111. doi:10.1158/1535-7163.MCT-06-0586 PubMedCrossRef

Choudhary S, Wang HCR (2007b) Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells. J Cancer Res Clin Oncol 133:725–739. doi:10.1007/s00432-007-0213-1 PubMedCrossRef

Chuang JI, Chang TY, Liu HS (2003) Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Oncogene 22:1349–1357. doi:10.1038/sj.onc.1206289 PubMedCrossRef

Doi S, Soda H, Oka M, Tsurutani J, Kitazaki T, Nakamura Y, Fukuda M, Yamada Y, Kamihira S, Kohno S (2004) The histone deacetylase inhibitor FR901228 induces caspase dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells. Mol Cancer Ther 3:1397–1402PubMed

Dokmanovic M, Marks PA (2005) Prospects: histone deacetylase inhibitors. J Cell Biochem 96:293–304. doi:10.1002/jcb.20532 PubMedCrossRef

Espino PS, Drobic B, Dunn KL, Davie JR (2005) Histone modifications as a platform for cancer therapy. J Cell Biochem 94:1088–1102. doi:10.1002/jcb.20387 PubMedCrossRef

Fecteau KA, Mei J, Wang HCR (2002) Differential modulation of signaling pathways and apoptosis of ras-transformed cells by a depsipeptide FR901228. J Pharmacol Exp Ther 300:890–899. doi:10.1124/jpet.300.3.890 PubMedCrossRef

Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239–247. doi:10.1038/35041687 PubMedCrossRef

Furumai R, Matsuyama A, Kobashi N, Lee KH, Nishiyama M, Nakajima H, Takana A, Komatsu Y, Nishino N, Yoshida M, Horinouchi S (2002) FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res 62:4916–4921PubMed

Glaser KB, Li J, Staver MJ, Wei RQ, Albert DH, Davidsen SK (2003) Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun 310:529–536. doi:10.1016/j.bbrc.2003.09.043 PubMedCrossRef

Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, Yasumi T, Watanabe K, Nishikomori R, Nakayama T, Yonehara S, Toguchida J, Nakahata T (2003) FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Oncogene 22:9231–9242. doi:10.1038/sj.onc.1207184 PubMedCrossRef

Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275:1649–1652. doi:10.1126/science.275.5306.1649 PubMedCrossRef

Jakubowski W, Bartosz G (2000) 2, 7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure? Cell Biol Int 24:757–760. doi:10.1006/cbir.2000.0556 PubMedCrossRef

Kim BM, Chung HW (2003) Hypoxia/reoxygenation induces apoptosis through a ROS-mediated caspase-8/Bid/Bax pathway in human lymphocytes. Biochem Biophys Res Commun 363:745–750. doi:10.1016/j.bbrc.2007.09.024 CrossRef

Kim S, Moon A (2004) Capsaicin-induced apoptosis of H-ras-transformed human breast epithelial cells is Rac-dependent via ROS generation. Arch Pharm Res 27:845–849. doi:10.1007/BF02980177 PubMedCrossRef

Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM (2007) Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 67:4671–4678. doi:10.1158/0008-5472.CAN-06-2466 PubMedCrossRef

Li Y, Trush MA (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 253:295–299. doi:10.1006/bbrc.1998.9729 PubMedCrossRef

Liu R, Li B, Qiu M (2001) Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-alpha. Oncogene 20:1486–1496. doi:10.1038/sj.onc.1204214 PubMedCrossRef

López-Lázaro M (2007) Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 252:1–8. doi:10.1016/j.canlet.2006.10.029 PubMedCrossRef

Marks PA, Miller T, Richon VM (2003) Histone deacetylases. Curr Opin Pharmacol 3:344–351. doi:10.1016/S1471-4892(03)00084-5 PubMedCrossRef

Mitsushita J, Lambeth JD, Kamata T (2004) The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 64:3580–3585. doi:10.1158/0008-5472.CAN-03-3909 PubMedCrossRef

Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y (2006) Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J Pharmacol Exp Ther 319:1062–1069. doi:10.1124/jpet.106.110965 PubMedCrossRef

Nitobe J, Yamaguchi S, Okuyama M, Nozaki N, Sata M, Miyamoto T, Takeishi Y, Kubota I, Tomoike H (2003) Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res 57:119–128. doi:10.1016/S0008-6363(02)00646-6 PubMedCrossRef

Oxford G, Theodorescu D (2003) The role of Ras superfamily proteins in bladder cancer progression. J Urol 170:1987–1993. doi:10.1097/01.ju.0000088670.02905.78 PubMedCrossRef

Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97–110. doi:10.1016/j.drup.2004.01.004 PubMedCrossRef

Sadowska AM, Manuel-Y-Keenoy B, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 20:9–22. doi:10.1016/j.pupt.2005.12.007 PubMedCrossRef

Santillo M, Mondola P, Serù R, Annella T, Cassano S, Ciullo I, Tecce MF, Iacomino G, Damiano S, Cuda G, Paterno R, Martignetti V, Mele E, Feliciello A, Avvedimento EV (2001) Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr Biol 11:614–619. doi:10.1016/S0960-9822(01)00159-2 PubMedCrossRef

Sharp DA, Lawrence DA, Ashkenazi A (2005) Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J Biol Chem 280:19401–19409. doi:10.1074/jbc.M413962200 PubMedCrossRef

Shigematsu N, Ueda H, Takase S, Tanaka H (1994) FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968: II. Structure determination. J Antibiot 47:311–314PubMed

Shinohara M, Shang WH, Kubodera M, Harada S, Mitsushita J, Kato M, Miyazaki H, Sumimoto H, Kamata T (2007) Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 282:17640–17648. doi:10.1074/jbc.M609450200 PubMedCrossRef

Song P, Wei J, Wang HCR (2005) Distinct roles of the ERK pathway in modulating apoptosis of Ras-transformed and non-transformed cells induced by anticancer agent FR901228. FEBS Lett 579:90–94. doi:10.1016/j.febslet.2004.11.050 PubMedCrossRef

Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW (1997) Substrate specificities of caspase family proteases. J Biol Chem 272:9677–9682. doi:10.1074/jbc.272.15.9677 PubMedCrossRef

Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M, Wigler M (1982) Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300:762–765. doi:10.1038/300762a0 PubMedCrossRef

Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao P, Achanta G, Arlinghaus R, Liu J (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10:241–252. doi:10.1016/j.ccr.2006.08.009 PubMedCrossRef

Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T, Okuhara M (1994) FR901228, a novel antitumor bicyclic depsipeptide produced by Chromabacterium violaceum No. 968: I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J Antibiot 47:301–310PubMed

Urquhart JL, Meech SJ, Marr DG, Shellman YG, Duke RC, Norris DA (2002) Regulation of Fas-Mediated Apoptosis by N-ras in Melanoma. J Invest Dermatol 119:556–561. doi:10.1046/j.1523-1747.2002.01854.x PubMedCrossRef

Vigushin DM (2002) FR-901228 Fujisawa/National Cancer Institute. Curr Opin Investig Drugs 3:1396–1402PubMed

Wang DS, Rieger-Christ K, Latini JM, Moinzadeh A, Stoffel J, Pezza JA, Saini K, Libertino JA, Summerhayes IC (2000) Molecular analysis of PTEN and MXI1 in primary bladder carcinoma. Int J Cancer 88:620–625. doi:10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z PubMedCrossRef

Wu XR (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5:713–725. doi:10.1038/nrc1697 PubMedCrossRef

Yang JQ, Li S, Domann FE, Buettner GR, Oberley LW (1999) Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells. Mol Carcinog 26:180–188. doi:10.1002/(SICI)1098-2744(199911)26:3<180::AID-MC7>3.0.CO;2-4 PubMedCrossRef

Titel: Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction
verfasst von: Shambhunath Choudhary
Hwa-Chain Robert Wang
Publikationsdatum: 01.11.2009
Verlag: Springer-Verlag
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-009-0608-2

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2009

Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis

Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett’s oesophagus and adenocarcinoma

BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients

Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions

Protein expression following γ-irradiation relevant to growth arrest and apoptosis in colon cancer cells

Standardized genetic alteration score and predicted score for predicting recurrence status of gastric cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie